✦ LIBER ✦

PCN2: DOSES OF OLANZPINE, RISPERIDONE, AND HALOPERIDOL IN CLINICAL PRACTICE: RESULTS OF A PROSPECTIVE PHARMACOEOPIDEMIOGICAL STUDY (EFESO)

✍ Scribed by JA Sacristán; JC Gómez; KJ Gregor; AL Montejo; E Vieta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doses of olanzapine, risperidone, and ha

✍ J.A. Sacristán; J.C. Gómez; K.J. Gregor; A.L. Montejo; E. Vieta 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Combined Mycophenolate Mofetil and Minim

✍ S. Beckebaum; C.G. Klein; G.C. Sotiropoulos; F.H. Saner; G. Gerken; A. Paul; V.R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Implant survival after sinus elevation w

✍ Ugo Covani; Bruno Orlando; Luca Giacomelli; Roberto Cornelini; Antonio Barone 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Incidence and Correlates of Drug-Eluting

✍ Peter Wenaweser; Joost Daemen; Marcel Zwahlen; Ron van Domburg; Peter Jüni; Soph 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Predictive value of the CARD15 variant 1

✍ Julia Seiderer; Stephan Brand; Karin A. Herrmann; Fabian Schnitzler; Rudolf Hatz 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Prostate-Specific Antigen (PSA) Isoform

✍ Giorgio Guazzoni; Luciano Nava; Massimo Lazzeri; Vincenzo Scattoni; Giovanni Lug 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 473 KB